Literature DB >> 6368598

A study of the Ca antigen in epithelial tumours of the ovary.

A M Ferguson, H Fox.   

Abstract

The expression of Ca antigen in ovarian epithelial tumours has been studied by an immunohistochemical technique using the Ca 1 monoclonal antibody. The antigen was found to be present in some examples of each of the histological subtypes of ovarian epithelial neoplasms and was detected in benign, borderline and malignant tumours. It is concluded that the presence of Ca antigen is of no discriminatory value in the assessment of malignancy in ovarian epithelial neoplasms.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6368598      PMCID： PMC498608          DOI： 10.1136/jcp.37.1.6

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  2 in total

1.  A new marker for human cancer cells. 1 The Ca antigen and the Ca1 antibody.

Authors:  F Ashall; M E Bramwell; H Harris
Journal:  Lancet       Date:  1982-07-03       Impact factor: 79.321

2.  Structure and function of the Ca antigen.

Authors:  M E Bramwell; V P Bhavanandan; G Wiseman; H Harris
Journal:  Br J Cancer       Date:  1983-08       Impact factor: 7.640
  2 in total
  5 in total

1.  Ca antigen and urothelial antibacterial defences: hypothesis.

Authors:  J A Morris; K Oates; W G Staff
Journal:  J Clin Pathol       Date:  1986-06       Impact factor: 3.411

2.  Localisation of Ca and HMFG2 antigens in breast tissue by immunoperoxidase, immunofluorescence, and immunoelectron microscopy.

Authors:  U Beckford; C Barbatis; J E Beesley; J C Linsell; S M Chantler
Journal:  J Clin Pathol       Date:  1985-05       Impact factor: 3.411

3.  Isolation and chemical and immunochemical characterization of the peanut-lectin-binding glycoprotein from human milk-fat-globule membranes.

Authors:  J Fischer; P J Klein; G H Farrar; F G Hanisch; G Uhlenbruck
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

4.  Immunocytochemical reaction of Ca1 and HMFG2 monoclonal antibodies with cells from serous effusions.

Authors:  S Singer; M M Boddington; E A Hudson
Journal:  J Clin Pathol       Date:  1985-02       Impact factor: 3.411

5.  c-erbB-2 and the "triple-state" in early breast carcinomas.

Authors:  Efthimios Sivridis; Charilaos Stamos; Aliki Fiska; Nikolaos Nikolettos; Michael I Koukourakis; Alexandra Giatromanolaki
Journal:  Med Oncol       Date:  2009-06-23       Impact factor: 3.064
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.